General Information of the Compound
Compound ID |
CP0860531
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-{2-[{2-[2-(Acetyl-butyl-amino)-acetylamino]-acetyl}-(4-amino-butyl)-amino]-acetylamino}-N-{[1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-methyl}-N-(3-guanidino-propyl)-3-phenyl-propionamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C44H65N13O8
|
||||||||||||||||||
Molecular Weight |
904.087
|
||||||||||||||||||
Canonical SMILES |
CCCCN(CC(=O)NCC(=O)N(CCCCN)CC(=O)N[C@@H](Cc1ccccc1)C(=O)N(CCCN=C(N)N)CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(N)=O)C(C)=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C44H65N13O8/c1-3-4-19-55(30(2)58)27-38(60)51-26-41(63)56(20-11-10-17-45)28-39(61)54-36(22-31-13-6-5-7-14-31)43(65)57(21-12-18-49-44(47)48)29-40(62)53-35(42(64)52-25-37(46)59)23-32-24-50-34-16-9-8-15-33(32)34/h5-9,13-16,24,35-36,50H,3-4,10-12,17-23,25-29,45H2,1-2H3,(H2,46,59)(H,51,60)(H,52,64)(H,53,62)(H,54,61)(H4,47,48,49)/t35-,36-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
BKCCPXJADVBUPG-ZPGRZCPFSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00914, Melanocortin receptor 4
Protein ID: PT01528, Melanocortin receptor 5